NEOS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NEOS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Neos Therapeutics's land and improvements for the quarter that ended in Sep. 2020 was $0.00 Mil.
The historical data trend for Neos Therapeutics's Land And Improvements can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neos Therapeutics Annual Data | ||||||||||||||||
Trend | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | |||||||||
Land And Improvements | Get a 7-Day Free Trial | - | - | - | - | - |
Neos Therapeutics Quarterly Data | ||||||||||||||||||||
Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | |
Land And Improvements | Get a 7-Day Free Trial | - | - | - | - | - |
Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.
Alan L Heller | director | BAXTER INTERNATIONAL INC ONE BAXTER PKWY DF2-2W DEERFIELD IL 60015 |
Gregory J Robitaille | director | |
John P. Schmid | director | 6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO CA 92121 |
Beth Hecht | director | C/O NEOS THERAPEUTICS, INC., 2940 N. HIGHWAY 360, GRAND PRAIRIE TX 75050 |
Linda M Szyper | director | C/O NEOS THERAPEUTICS, INC., 2940 N. HIGHWAY 250, SUITE 400, GRAND PRAIRIE TX 75050 |
Bryant Fong | director | 2170 VALLEJO STREET #101, SAN FRANCISCO CA 94123 |
Robinson James A. Jr. | director | 852 WINTER STREET, WALTHAM MA 02451 |
Gerald W. Mclaughlin | director, officer: Chief Executive Officer | 227 WASHINGTON STREET, SUITE 200, CONSHOHOCKEN PA 19428 |
Richard I Eisenstadt | officer: Chief Financial Officer | 4819 EMPEROR BOULEVARD, SUITE 400, DURHAM NC 27703 |
John M Limongelli | officer: SVP & General Counsel | 700 PENNSYLVANIA DRIVE, EXTON PA 19341 |
Thomas P Mcdonnell | officer: Chief Commercial Officer | C/O NEOS THERAPEUTICS, INC. 2940 N. HIGHWAY 360 GRAND PRAIRIE TX 75050 |
Vipin K Garg | officer: Chief Executive Officer | 4819 EMPEROR BOULEVARD, SUITE 400, DURHAM NC 27703 |
Dorothy Engelking | officer: VP, Regulatory Affairs | C/O NEOS THERAPEUTICS, INC. 2940 N. HIGHWAY 360 GRAND PRAIRIE TX 75050 |
Paul R Edick | director | C/O NEWLINK GENETICS CORP., 2503 SOUTH LOOP DR., SUITE 5100, AMES IA 50010 |
Juergen Martens | officer: Chief Tech/Operations Officer | 28903 NORTH AVENUE PAINE, VALENCIA CA 91355 |
From GuruFocus
By Marketwired Marketwired • 05-02-2019
By Marketwired Marketwired • 12-11-2020
By PRNewswire PRNewswire • 01-31-2021
By Marketwired Marketwired • 05-12-2020
By Marketwired Marketwired • 06-16-2020
By Marketwired Marketwired • 05-26-2020
By Marketwired Marketwired • 01-13-2020
By Marketwired Marketwired • 09-25-2019
By Marketwired Marketwired • 12-10-2020
By Marketwired Marketwired • 08-03-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.